Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Jennifer E. Cook, a director at BridgeBio Pharma, Inc. (NASDAQ: BBIO), executed a series of complex transactions on July 9, 2026, involving the sale and acquisition of company stock. The director sold 148,589 shares valued at approximately $13.16 million under a Rule 10b5-1 plan, while simultaneously acquiring an equal number of shares through stoc…
Oguzhan Atay, Chairman and Chief Executive Officer of BillionToOne, Inc. (NASDAQ:BLLN), executed a sale of 12,500 shares of Class A Common Stock on July 9, 2026, realizing approximately $1.57 million in proceeds. The transactions were facilitated through a pre-existing Rule 10b5-1 trading plan established in March 2026. Despite the executive divest…
A consortium of reporting owners, including Aqua Capital, Ltd. and Durango Capital, Ltd., has acquired 60,000 shares of Energizer Holdings, Inc. (NASDAQ: ENR) for approximately $1.23 million. The transactions, executed on July 9 and July 10, 2026, bring the group's direct and indirect ownership to 7,480,000 shares, solidifying their status as a gre…
BillionToOne, Inc. (NASDAQ:BLLN) Chief Product Officer Sakakibara Shan Riku completed a $1,000,000 sale of 8,000 Class A Common Stock shares on July 9, 2026. The transaction, executed at $125 per share, was facilitated through a Rule 10b5-1 trading plan established on March 6, 2026. Concurrently, Sakakibara exercised fully vested stock options to a…
Datadog, Inc. (NASDAQ:DDOG) director Amit Agarwal has executed a significant sale of Class A Common Stock shares. The transaction, valued at approximately $5.35 million, was carried out through a pre-arranged trading plan. This activity occurs as the company faces contrasting analyst outlooks and continues its strategic focus on artificial intellig…
David A. Duffield, a principal 10% shareholder of Workday Inc., offloaded 107,500 Class A Common Stock shares on July 9, 2026, generating approximately $14.7 million in proceeds. The transaction, facilitated through a Rule 10b5-1 trading plan linked to a 2025 trust arrangement, involved converting an equal number of Class B shares prior to sale. Th…
Darin Lippoldt, the Chief Legal Officer at Neurocrine Biosciences Inc. (NASDAQ: NBIX), executed a sale of 10,000 shares of the company's common stock on July 9, 2026, totaling approximately $1.79 million. The transaction was conducted under a Rule 10b5-1 trading plan established prior to the sale. This activity occurs as the company navigates a per…
Grace & Mercy Foundation, Inc. has increased its direct ownership in Gloo Holdings, Inc. (NASDAQ:GLOO) through a recent purchase of Class A Common Stock. The transaction, executed as part of a broader firm commitment underwritten public offering, underscores the foundation's continued capital allocation into the company. This activity occurs agains…
Ooma Inc. CEO Eric Stang executed a direct sale of company stock in July, while the firm recently delivered fiscal 2027 first-quarter results that beat consensus estimates on earnings, revenue, and EBITDA. Following these financial beats, management raised its full-year outlook, and multiple investment firms adjusted their price targets upward or r…
Twist Bioscience Corp (NASDAQ:TWST) CFO Adam Laponis completed a non-discretionary sale of 2,399 shares on July 9, 2026, generating $226,307 to fulfill tax withholding duties tied to Restricted Stock Unit vesting. The transaction occurs amid a 9.3% weekly stock decline and heightened market volatility, even as analyst firms highlight the company’s …
HRT Financial LP, recognized as a 10% owner of Bluejay Diagnostics, Inc. (NASDAQ:BJDX), disclosed a combination of purchase and sale activity for the company's common stock. The firm sold shares valued at $48,913 while simultaneously acquiring stock worth $96,710. These transactions take place against a backdrop of recent corporate developments, in…
HRT Financial LP has increased its position in Shuttle Pharmaceuticals Holdings, Inc. through recent share purchases. The acquisition occurs as Shuttle Pharmaceuticals navigates significant corporate changes, including a completed merger and an approved reverse stock split. The company's stock has experienced substantial declines over recent period…
QNB Corp. director Joseph W Major recently increased his stake in the company through a targeted purchase of common stock, according to regulatory filings. The transaction underscores continued executive confidence as the financial institution advances its operational integration and maintains a long-standing dividend record. This activity occurs w…
Azar Samak L, the Chief Legal Officer at GLOBALFOUNDRIES Inc. (NASDAQ:GFS), recently executed a sale of 335 ordinary shares on July 9, 2026, generating proceeds of $23,751. The transaction, conducted at a price of $70.90 per share, was carried out under a Rule 10b5-1 trading plan previously established by the executive. Following this sale, Samak L…
Atlas Infrastructure Partners (UK) Ltd. executed a strategic acquisition of H2O America (NASDAQ:HTO) shares on July 7, 2026, reinforcing its position as a significant shareholder. This transaction occurs against a backdrop of mixed Q1 2026 financial performance for HTO, where earnings and revenue fell short of analyst expectations, yet market react…
Horizon Kinetics Asset Management LLC has increased its direct holding in Texas Pacific Land Corp (NYSE: TPL) through a recent purchase, while the energy and land management company reported first-quarter 2026 financial results that exceeded analyst expectations. The acquisition occurs alongside a strategic agreement with Chevron for Project Kilby …
Horizon Kinetics Asset Management LLC, which serves as the investment adviser to RENN Fund, Inc., executed a recent acquisition of the fund's common stock. The transaction, valued at $2,283, involved the purchase of 756 shares on July 10, 2026, bringing the firm's total direct holding to 933,420 shares. As a significant 10% owner, Horizon Kinetics …
Peter R. Matt, President and CEO of Commercial Metals Co (NYSE:CMC), increased his direct ownership stake through a recent equity purchase. The transaction occurred alongside the company reporting fiscal third-quarter 2026 financial metrics that surpassed consensus estimates. While management activity and earnings strength suggest internal confiden…
Jorey Chernett, a significant 10% shareholder in The Oncology Institute, Inc. (NASDAQ: TOI), executed a direct purchase of 15,000 shares on July 10, 2026, valued at $87,750. This transaction brings Chernett's total holding to 10,630,858 shares. The insider buying activity occurs as TOI trades near its 52-week high of $6.11, supported by recent corp…
Saba Capital Management, L.P. has executed a significant divestment from BlackRock ESG Capital Allocation Term Trust (NASDAQ:ECAT), selling common shares valued at approximately $2.08 million. The transactions occurred over two consecutive days in July 2026, reflecting a strategic reduction in a trust that currently offers a substantial dividend yi…
Coastlands Capital LP, a significant 10% shareholder in ADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL), has increased its stake through recent open-market purchases. This activity coincides with broader corporate developments, including a private placement financing event and strategic asset acquisitions that aim to expand the company's therapeutic pipe…
Mahesh Choudhury, Principal Financial Officer of ConnectM Technology Solutions, Inc. (NASDAQ:CNTM), has acquired 3,622 shares of the company's common stock over a five-day period. The purchases, totaling approximately $31,766, occurred between June 22, 2026, and June 26, 2026. Choudhury's transactions took place while the stock was declining, with …
Anixa Biosciences CEO Amit Kumar acquired 5,000 shares at $3.04 per share on July 10, 2026, increasing his direct holdings to 635,812 shares. The transaction coincides with the company's clinical trial milestones and the grant of a South Korean patent for its breast cancer vaccine technology. Despite recent progress, the company reported a net loss…
IperionX Ltd (NASDAQ:IPX) Chief Executive Officer Anastasios Arima executed a significant personal equity purchase, acquiring 138,720 ordinary shares valued at approximately $497,227 on July 10, 2026. This transaction occurs against a backdrop of recent corporate financing activities and analyst coverage, signaling continued strategic alignment bet…
Todd Hannigan, serving as Executive Chairman of IperionX Ltd (NASDAQ:IPX), has significantly increased his direct ownership in the company through recent share acquisitions. This activity occurs against a backdrop of substantial stock price declines over the past six months, despite ongoing analyst optimism and a recent public offering. The transac…
